News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
638
Sources here
20
Companies here
19
Search results Stored financial headlines

Active search

638 matching headlines

Ticker or company: ARTEMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Star Equity to acquire Harte Hanks for $5.00 per share By Investing.com

Star Equity Holdings, Inc. has entered into a merger agreement to acquire Harte Hanks, Inc. for $5.00 per share, valuing the customer experience company at approximately $38.4 million. The consideration will be split between cash and Star 10% Series A Cumulative Perpetual Preferred Stock, …

HHS main company
Sharemaestro market context New activity signal 52 weeks +17.5% · Next-week setup negative 30.7% HHS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Harte Hanks Holders May Elect Cash or Star Preferred Stock

Star Equity Holdings has entered into a definitive merger agreement to acquire Harte Hanks for $5.00 per share, totaling approximately $38.4 million. The consideration will be up to 50% cash and the remainder in Star's 10% Series A Cumulative Perpetual Preferred Stock, with no …

HHS main company
Sharemaestro market context New activity signal 52 weeks +17.5% · Next-week setup negative 30.7% HHS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Star Equity to acquire Harte Hanks for $5 per share in cash-stock deal

Star Equity Holdings, Inc. (NASDAQ:STRR) announced its plan to acquire Harte Hanks, Inc. (NASDAQ:HHS) for $5.00 per share, totaling an aggregate equity value of $38.4 million. Harte Hanks shareholders can choose between cash or Star Equity's preferred stock, and the transaction includes a 30-day …

HHS main company
Sharemaestro market context New activity signal 52 weeks +17.5% · Next-week setup negative 30.7% HHS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Harte Hanks stock rises on $5 per share acquisition deal

Harte Hanks Inc. (NASDAQ:HHS) shares rose in premarket trading after Star Equity Holdings Inc. (NASDAQ:STRR) announced it would acquire the company for $5.00 per share, valuing Harte Hanks at approximately $38.4 million. Shareholders can choose between cash or Star Equity preferred stock for their …

HHS main company
Sharemaestro market context New activity signal 52 weeks +17.5% · Next-week setup negative 30.7% HHS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share

Harte Hanks has entered into a definitive merger agreement to be acquired by Star Equity Holdings for $5.00 per share, an aggregate equity value of $38.4 million. This represents approximately a 100% premium to Harte Hanks' unaffected share price. Shareholders can elect to receive …

HHS main company
Sharemaestro market context New activity signal 52 weeks +17.5% · Next-week setup negative 30.7% HHS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

California approves Charter's $21.9 billion Cox Communications merger

The California Public Utilities Commission voted unanimously Thursday to approve Charter Communications' $21.9 billion acquisition of Cox Communications, clearing the final regulatory hurdle before the deal closes. California was the last state to grant approval, according to the Wall Street Journal. The other 44 …

CHTR main company CHTR main company
Sharemaestro market context Price below Trend Line 52 weeks -47.7% · Next-week setup negative 27.5% CHTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Charter-Cox merger gets final state approval

[Cable Giants Cox And Charter Communications Agree To $34.5 Billion Merger] Kevin Dietsch/Getty Images News California has greenlit Charter Communications' (CHTR [https://seekingalpha.com/symbol/CHTR]) $34.5B deal to buy cable TV and broadband provider Cox Communications, with the merger expected to close next week. The California Public …

CHTR main company CHCM34 main company CHTR main company CHTR main company
Sharemaestro market context Price below Trend Line 52 weeks -47.7% · Next-week setup negative 27.5% CHTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Charter Communications (CHTR) After Its Spectrum Optimum Deal And The Case For Fair Value

Charter Communications (CHTR) has gained attention after its Spectrum unit and Optimum expanded local news distribution and advertising collaboration. Despite recent positive short-term share price momentum, longer-term returns remain negative. The company is considered undervalued with a narrative fair value of $294.71, supported by …

CHTR main company
Sharemaestro market context New activity signal 52 weeks -44.4% CHTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What Charter Communications (CHTR)'s Expanded Local News and Ad Partnership Means for Shareholders

Charter Communications (CHTR) recently expanded its local news and advertising partnership with Optimum, restoring Spectrum News NY1 and News 12 carriage in New York and adding Spectrum News channels for Optimum TV customers in Texas and North Carolina. This deal aims to enhance how …

CHTR main company
Sharemaestro market context New activity signal 52 weeks -44.4% CHTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Carter's Earnings Rebound and Buybacks Could Be A Game Changer For Carter's (CRI)

Carter's (CRI) recently reported strong Q2 2026 results with increased sales and net income, alongside a significant share repurchase program. The company projects modest net sales growth for fiscal 2026, shifting the focus to operational execution and cost discipline for future profitability. While earnings …

CRI main company
Sharemaestro market context Trend signal active 52 weeks +52.0% CRI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barclays PLC (RNAC) discloses 1.76M-share, 5.99% holding in Cartesian Therapeutics

Barclays PLC has reported a 5.99% stake in Cartesian Therapeutics Inc. (RNAC), holding 1,760,326 shares of common stock as of June 30, 2026. The filing indicates that Barclays PLC has sole voting power over 1,739,724 shares and shared voting power over 20,602 shares. This …

RNAC main company
Sharemaestro market context Trend signal active 52 weeks -21.3% RNAC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CARTERS INC (CRI) officer has 1,124 shares withheld for taxes after vesting

Karen Marie Smith, Chief Supply Chain Officer at CARTERS INC (CRI), reported a tax-related share disposition where 1,124 shares were withheld at $39.06 per share to cover tax obligations from the vesting of restricted stock. Following this transaction on August 12, 2026, she directly …

CRI main company
Sharemaestro market context Trend signal active 52 weeks +52.0% CRI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Liberty Broadband Corp (CHTR) trims Charter stake in issuer transaction

Liberty Broadband Corp, a significant shareholder and director of Charter Communications, Inc. (CHTR), has reported an indirect disposition of 9,900 Class A Common Stock shares. This transaction occurred on August 13, 2026, at a price of $133.86 per share, and was categorized as an …

CHTR main company
Sharemaestro market context New activity signal 52 weeks -44.4% CHTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AIP (AIP) insider Nicholas Hawkins outlines planned sale of 10,431 shares

Nicholas Hawkins, an insider at Arteris, Inc. (AIP), has filed to sell 10,431 shares of common stock, valued at approximately $294,828.04, through Morgan Stanley Smith Barney LLC. This proposed sale includes shares from restricted stock vesting on July 6, 2026, and an option exercise …

AIP main company
Sharemaestro market context Trend signal active 52 weeks +184.1% AIP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Artelo Biosciences Releases Q2 2026 Financial Results

Artelo Biosciences, Inc. reported a net loss of $2.4M and a loss of $0.89 per share for Q2 2026, marking a significant improvement from the $16.8 per-share loss in Q2 2025. The clinical-stage biopharmaceutical company continues to advance its therapeutic pipeline targeting lipid-signaling pathways, …

ARTL main company
Sharemaestro market context Price below Trend Line 52 weeks -97.2% · Next-week setup negative 38.6% ARTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Artelo Plans Q4 Trial After ART26.12 Matches Naproxen for Pain

Artelo Biosciences reported its Q2 2026 financial results, with a narrowed net loss of $2.4 million and positive pipeline updates. The company plans a Phase 1 multiple ascending dose study for ART26.12 in Q4 2026, which has shown pain relief comparable to naproxen in …

ARTL main company
Sharemaestro market context Price below Trend Line 52 weeks -97.2% · Next-week setup negative 38.6% ARTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Charter Communications Inc. - Ordinary Shares - Class A (CHTR) News, Articles, Events & Latest Updates

This article provides recent news and updates for Charter Communications Inc. (CHTR), including an insider sell by Liberty Broadband Corp, strategic collaborations with Optimum, and various debt-related announcements. It also touches on analyst reactions to recent earnings and the company's stock performance.

CHTR main company
Sharemaestro market context New activity signal 52 weeks -44.4% CHTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Artelo Biosciences (ARTL) investors disclose 4.8% stake via Intracoastal warrant

Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC have disclosed a 4.8% beneficial ownership stake in Artelo Biosciences (ARTL) through a warrant held by Intracoastal. This ownership amounts to 173,914 shares of common stock, issuable upon the warrant's exercise, and is based …

ARTL main company
Sharemaestro market context Price below Trend Line 52 weeks -97.2% · Next-week setup negative 38.6% ARTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results

Artelo Biosciences Clinical and Scientific Progress Across the Pipeline Supports Multiple Upcoming Milestones SOLANA BEACH, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for …

ARTL main company
Sharemaestro market context Price below Trend Line 52 weeks -97.2% · Next-week setup negative 38.6% ARTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Marten Transport notes better operating environment for segments

Marten Transport reported an improved operating environment across its segments in Q2, with its truckload segment's operating ratio improving from 100.9% in Q1 to 97.9%. The company attributed this to a tightening freight market, influenced by federal policies affecting trucking capacity. Marten Transport also …

MRTN main company
Sharemaestro market context Trend signal active 52 weeks +25.1% MRTN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arteris | 144: Notice of proposed sale of securities pursuant to Rule 144

This article is a notice of a proposed sale of securities by Arteris, filed pursuant to Rule 144. It indicates that the company is intending to sell securities as per regulatory requirements.

AIP main company
Sharemaestro market context Trend signal active 52 weeks +184.1% AIP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mizuho Securities Maintains Cartesian Therapeutics(RNAC.US) With Buy Rating, Maintains Target Price $40

Mizuho Securities has reiterated its Buy rating on Cartesian Therapeutics (RNAC.US), maintaining a target price of $40. This indicates a continued positive outlook from the firm regarding the company's stock performance.

RNAC main company
Sharemaestro market context Trend signal active 52 weeks -21.3% RNAC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Artesian Resources Reports Increased Revenue and Earnings in Q2 2026

Artesian Resources Corporation reported increased revenue and net income for Q2 2026, with total operating revenues reaching $30,664 thousand and net income of $6,575 thousand. The company also saw growth in total assets and declared cash dividends for its shareholders. These results reflect a …

ARTNA main company
Sharemaestro market context Trend signal active 52 weeks +8.9% · Next-week setup negative 40.4% ARTNA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider (AIP) files Form 144 notice for 200-share stock sale

Nicholas B. Hawkins, an insider at Arteris, Inc. (AIP), has filed a Form 144 notice to sell 200 shares of common stock through Morgan Stanley Smith Barney LLC on August 12, 2026, with an aggregate market value of $5,800. These shares stem from restricted …

AIP main company
Sharemaestro market context Trend signal active 52 weeks +184.1% AIP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Artelo Biosciences (ARTL) trims liabilities, boosts cash amid $5.4M H1 loss

Artelo Biosciences reported a net loss of $5.4 million for the first half of 2026 but significantly improved its liquidity and balance sheet. The company increased cash and cash equivalents to $4.2 million from $0.6 million at year-end 2025 and reduced total liabilities from …

ARTL main company
Sharemaestro market context Price below Trend Line 52 weeks -97.2% · Next-week setup negative 38.6% ARTL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context